Home Tools
Log in
Cart

Search Result

Search Results for " bta 585 "

2

Compounds

Cat No. Product Name Synonyms Targets
T27271 Enzaplatovir BTAC585,BTA 585,BTA585,BTA-C585,BTA-585 RSV
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
T37883 (S)-Enzaplatovir
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV)[1].
TargetMol